<p>To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 October 2018 to Question 178508 on Drugs: Prices, for what reasons (a) the consultation on a new system of commissioning for special medicinal products has not begun and (b) unwarranted prices of unbranded generic medicines continues 18 months after the passing of the Health Service Medical Supplies (Costs) Act 2017.</p>